These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22673692)

  • 1. Colloidal systems for drug delivery: from design to therapy.
    Beija M; Salvayre R; Lauth-de Viguerie N; Marty JD
    Trends Biotechnol; 2012 Sep; 30(9):485-96. PubMed ID: 22673692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in nanomedicines for malaria treatment.
    Aditya NP; Vathsala PG; Vieira V; Murthy RS; Souto EB
    Adv Colloid Interface Sci; 2013 Dec; 201-202():1-17. PubMed ID: 24192063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Past and future evolution in colloidal drug delivery systems.
    Boyd BJ
    Expert Opin Drug Deliv; 2008 Jan; 5(1):69-85. PubMed ID: 18095929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles.
    Tanner P; Baumann P; Enea R; Onaca O; Palivan C; Meier W
    Acc Chem Res; 2011 Oct; 44(10):1039-49. PubMed ID: 21608994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of stable colloidal nanoparticles with cellular membranes.
    Mahmoudi M; Meng J; Xue X; Liang XJ; Rahman M; Pfeiffer C; Hartmann R; Gil PR; Pelaz B; Parak WJ; Del Pino P; Carregal-Romero S; Kanaras AG; Tamil Selvan S
    Biotechnol Adv; 2014; 32(4):679-92. PubMed ID: 24361955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel approaches for drug delivery systems in nanomedicine: effects of particle design and shape.
    Daum N; Tscheka C; Neumeyer A; Schneider M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(1):52-65. PubMed ID: 22140017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging trends of nanomedicine--an overview.
    Sandhiya S; Dkhar SA; Surendiran A
    Fundam Clin Pharmacol; 2009 Jun; 23(3):263-9. PubMed ID: 19527298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric nanoparticles for drug delivery.
    Chan JM; Valencia PM; Zhang L; Langer R; Farokhzad OC
    Methods Mol Biol; 2010; 624():163-75. PubMed ID: 20217595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer drug delivery with nanoparticles.
    Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
    In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
    Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
    Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-mediated treatment of pulmonary arterial hypertension.
    Mosgoeller W; Prassl R; Zimmer A
    Methods Enzymol; 2012; 508():325-54. PubMed ID: 22449934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering of amphiphilic block copolymers for polymeric micellar drug and gene delivery.
    Xiong XB; Falamarzian A; Garg SM; Lavasanifar A
    J Control Release; 2011 Oct; 155(2):248-61. PubMed ID: 21621570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nanomedicine: application of nanotechnology in medicine. Opportunities in neuropsychiatry].
    Szebeni J
    Neuropsychopharmacol Hung; 2011 Mar; 13(1):15-24. PubMed ID: 21451188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A perspective of nanotechnology in hypersensitivity reactions including drug allergy.
    Montañez MI; Ruiz-Sanchez AJ; Perez-Inestrosa E
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):297-302. PubMed ID: 20485158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine: sizing up targets with nanoparticles.
    Minchin R
    Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442
    [No Abstract]   [Full Text] [Related]  

  • 16. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiopathological and physicochemical considerations in targeting of colloids and drug carriers to the bone marrow.
    Moghimi SM; Illum L; Davis SS
    Crit Rev Ther Drug Carrier Syst; 1990; 7(3):187-209. PubMed ID: 2073686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal nanomedicines.
    Fenske DB; Cullis PR
    Expert Opin Drug Deliv; 2008 Jan; 5(1):25-44. PubMed ID: 18095927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colloidal soft matter as drug delivery system.
    Bonacucina G; Cespi M; Misici-Falzi M; Palmieri GF
    J Pharm Sci; 2009 Jan; 98(1):1-42. PubMed ID: 18452176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assembling nanoparticle coatings to improve the drug delivery performance of lipid based colloids.
    Simovic S; Barnes TJ; Tan A; Prestidge CA
    Nanoscale; 2012 Feb; 4(4):1220-30. PubMed ID: 22159191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.